Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Fecal microbiome transplantation by low-volume enema is an effective, safe, and inexpensive alternative to antibiotic therapy for patients with chronic relapsing Clostridium difficile infection (CDI). We explored the microbial diversity of pre- and posttransplant stool specimens from CDI patients (n = 6) using deep sequencing of the 16S rRNA gene. While interindividual variability in microbiota change occurs with fecal transplantation and vancomycin exposure, in this pilot study we note that clinical cure of CDI is associated with an increase in diversity and richness. Genus- and species-level analysis may reveal a cocktail of microorganisms or products thereof that will ultimately be used as a probiotic to treat CDI. IMPORTANCE Antibiotic-associated diarrhea (AAD) due to Clostridium difficile is a widespread phenomenon in hospitals today. Despite the use of antibiotics, up to 30% of patients are unable to clear the infection and suffer recurrent bouts of diarrheal disease. As a result, clinicians have resorted to fecal microbiome transplantation (FT). Donor stool for this type of therapy is typically obtained from a spouse or close relative and thoroughly tested for various pathogenic microorganisms prior to infusion. Anecdotal reports suggest a very high success rate of FT in patients who fail antibiotic treatment (>90%). We used deep-sequencing technology to explore the human microbial diversity in patients with Clostridium difficile infection (CDI) disease after FT. Genus- and species-level analysis revealed a cocktail of microorganisms in the Bacteroidetes and Firmicutes phyla that may ultimately be used as a probiotic to treat CDI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While antibiotics are a major risk factor for CDI, community acquired CDI is becoming increasingly common in the absence of antibiotic use.49”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., & Glockner, F. O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm864 · Cited by 6,668
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 2×
“For example, perturbations of the distal gut microbiota and childhood antibiotic use have been previously implicated in chronic conditions such as asthma, life-threatening pseudomembranous colitis, cancer, and obesity (44, 45).”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 2×
“For example, perturbations of the distal gut microbiota and childhood antibiotic use have been previously implicated in chronic conditions such as asthma, life-threatening pseudomembranous colitis, cancer, and obesity (44, 45).”
BackgroundHost-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“the highest taxonomic level available (44, 45, 50, 51).”
BackgroundThe Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Microbial diversity in the deep sea and the underexplored “rare biosphere”
Sogin, M. L., Morrison, H. G., Huber, J. A., Welch, D. M., Huse, S. M., Neal, P. R., Arrieta, J. M., & Herndl, G. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605127103 · Cited by 3,701
Meyer, F., Paarmann, D., D'Souza, M., Olson, R., Glass, E., Kubal, M., Paczian, T., Rodriguez, A., Stevens, R., Wilke, A., et al. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-386 · Cited by 3,565
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“the highest taxonomic level available (44, 45, 50, 51).”
BackgroundBacterial Community Variation in Human Body Habitats Across Space and Time
Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., & Knight, R. (2009) · Science · doi:10.1126/science.1177486 · Cited by 3,231 · cited 2×
“(or group of sequences) as their nearest neighbor (19, 32).”
BackgroundResultCohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 7×
“discovery procedure were chosen for the comparison of community memberships and structures on the basis of the thoroughness of the results previously published for this type of analysis with pooled data using the refOTU approach (19).”
BackgroundMethodResultInfluentialAn Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1817 · Cited by 1,711
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Wang, Y., & Qian, P.-Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007401 · Cited by 1,265
The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data
Cole, J. R., Chai, B., Farris, R. J., Wang, Q., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Bandela, A. M., Cardenas, E., Garrity, G. M., & Tiedje, J. M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl889 · Cited by 1,165
Duncan, S. H., Louis, P., & Flint, H. J. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.5810-5817.2004 · Cited by 1,129
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Exploring Microbial Diversity and Taxonomy Using SSU rRNA Hypervariable Tag Sequencing
Huse, S. M., Dethlefsen, L., Huber, J. A., Welch, D. M., Relman, D. A., & Sogin, M. L. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000255 · Cited by 1,001
Claesson, M. J., Wang, Q., O'Sullivan, O., Greene-Diniz, R., Cole, J. R., Ross, R. P., & O'Toole, P. W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq873 · Cited by 980
(1958) · PubMed · Cited by 978
Duncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M., Flint, H. J., & Lobley, G. E. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02340-06 · Cited by 941 · cited 6×
“It is possible that the microbial equilibrium is specifically altered by commonly used antibiotics such as the newer-generation fluoroquinolones which have increased activity against healthy Bacteroides, lower activity against Proteobacteria, and no activity against the epidemic North American pulsotype (NAP) 1 strain…”
InfluentialPotential Uses of Probiotics in Clinical Practice
Reid, G., Jass, J., Sebulsky, M. T., & McCormick, J. K. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.658-672.2003 · Cited by 912
From the gut to the peripheral tissues: the multiple effects of butyrate
Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., & Van Immerseel, F. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000247 · Cited by 806
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 3×
“It has been suggested that the CDI state is marked by reduced microbial diversity and that persistent disruption of commensal microbe-gut interactions may result in interference with the complex interactions between the host and the commensal gut microbiota of healthy individuals (11, 12, 18).”
BackgroundMethodContribution of acetate to butyrate formation by human faecal bacteria
Duncan, S. H., Holtrop, G., Lobley, G. E., Calder, A. G., Stewart, C. S., & Flint, H. J. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041150 · Cited by 449
Costa, M. C., Arroyo, L. G., Allen-Vercoe, E., Stämpfli, H. R., Kim, P. T., Sturgeon, A., & Weese, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041484 · Cited by 425
Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain
O'Connor, J. R., Johnson, S., & Gerding, D. N. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.073 · Cited by 357
Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649213 · Cited by 278
Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora
Grehan, M. J., Borody, T. J., Leis, S. M., Campbell, J., Mitchell, H., & Wettstein, A. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e5d06b · Cited by 253
In vitro activity of BAY 12-8039, a new fluoroquinolone
Woodcock, J. M., Andrews, J. M., Boswell, F. J., Brenwald, N. P., & Wise, R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.101 · Cited by 251
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Bakken, J. S. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.09.007 · Cited by 218
Tannock, G. W., Munro, K., Taylor, C., Lawley, B., Young, W., Byrne, B., Emery, J., & Louie, T. (2010) · Microbiology · doi:10.1099/mic.0.042010-0 · Cited by 217
Relapsing Clostridium difficile Enterocolitis Cured by Rectal Infusion of Normal Faeces
Schwan, A., Sjolin, S., Trottestam, U., & Aronsson, B. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087145 · Cited by 201
RELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECES
SCHWAN, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90753-5 · Cited by 196
Glass, E. M., & Meyer, F. (2011) · Handbook of Molecular Microbial Ecology I · doi:10.1002/9781118010518.ch37 · Cited by 188
Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection
Silverman, M. S., Davis, I., & Pillai, D. R. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.01.007 · Cited by 181
Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.
Bowden, T. A., Ar, M., & Le, L. (1981) · PubMed · Cited by 179
Sodium-butyrate as a growth promoter in milk replacer formula for young calves
Guilloteau, P., Zabielski, R., David, J. C., Blum, J. W., Morisset, J., Biernat, M., Woliński, J., Laubitz, D., & Hamon, Y. (2009) · Journal of Dairy Science · doi:10.3168/jds.2008-1213 · Cited by 171
Storey, J. D., Dai, J. Y., & Leek, J. T. (2006) · Biostatistics · doi:10.1093/biostatistics/kxl019 · Cited by 154
Manges, A. R., Labbe, A., Loo, V. G., Atherton, J. K., Behr, M. A., Masson, L., Tellis, P. A., & Brousseau, R. (2010) · The Journal of Infectious Diseases · doi:10.1086/657319 · Cited by 149
MedlineRanker: flexible ranking of biomedical literature
Fontaine, J.-F., Barbosa-Silva, A., Schaefer, M., Huska, M. R., Muro, E. M., & Andrade-Navarro, M. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp353 · Cited by 147
Guilloteau, P., Savary, G., Jaguelin-Peyrault, Y., Rome, V., Normand, L. L., & Zabielski, R. (2010) · Journal of Dairy Science · doi:10.3168/jds.2009-2751 · Cited by 84
Goldstein, E. J. C., Citron, D. M., Warren, Y. A., Tyrrell, K. L., Merriam, C. V., & Fernandez, H. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.148-155.2006 · Cited by 69
Emergence of Clostridium difficile NAP1 in Latin America
Quesada-Gómez, C., Rodríguez, C., Gamboa-Coronado, M. D. M., Rodríguez-Cavallini, E., Du, T., Mulvey, M. R., Villalobos-Zúñiga, M. A., & Boza-Cordero, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02196-09 · Cited by 63
Lavallée, C., Laufer, B., Pépin, J., Mitchell, A., Dubé, S., & Labbé, A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03004.x · Cited by 36
Finegold, S. M., John, S. S., Vu, A., Li, C. M., Molitoris, D. R., Song, Y., Liu, C., & Wexler, H. M. (2004) · Anaerobe · doi:10.1016/j.anaerobe.2004.04.003 · Cited by 28
A computationally efficient modular optimal discovery procedure
Woo, S., Leek, J. T., & Storey, J. D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq701 · Cited by 15
Surveillance Data on Outbreaks ofClostridiumdifficileInfection in Ontario, Canada, in 2008–2009
Pillai, D. R., Longtin, J., & Low, D. E. (2010) · Clinical Infectious Diseases · doi:10.1086/653007 · Cited by 12
First-born may be at greater risk for diabetes and hypertension
Sivagnanam, G. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.110922 · Cited by 1
Cited by
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Kao, D., Roach, B., Silva, M., Beck, P., Rioux, K., Kaplan, G. G., Chang, H.-J., Coward, S., Goodman, K. J., Xu, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.17077 · Cited by 615
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
“difficile.(50) Bacillus thuringensis secretes a bacteriocin, thuricin CD, with narrow spectrum activity against gram positive bacteria including C.”
Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., & Wang, G. P. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-13 · Cited by 485
“Consistent with previous studies (17, 19, 20, 32), our FIG 5 Bacteria genera most depleted or enriched in CDI and CDN.”
Result
Metadata
- Authors
- Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R.
- Affiliations
- University of Toronto (CA)
- Lakeridge Health (CA)
- University of California, San Francisco (US)
- University of Guelph (CA)
- Department of Molecular and Cell Biology, University of Guelph, Guelph, Ontario, Canada
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada
- Queen's University (CA)
- Mount Sinai Hospital (CA)
- University of Calgary (CA)
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2012-11
- Volume
- 3
- Issue
- 5
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC3482503
- OpenAlex
- W2148389200
- Cited by
- 191
- References
- 52
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 10 · 2020: 13 · 2019: 12 · 2018: 17 · 2017: 17 · 2016: 25 · 2015: 18 · 2014: 22 · 2013: 24 · 2012: 1
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Michigan
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile infection, microbial diversity, 16S rRNA gene sequencing, vancomycin, antibiotic-associated diarrhea, probiotics, Bacteroidetes, Firmicutes, interindividual variability
- MeSH terms
- Clostridium Infections, Feces, Humans, Clostridioides difficile, Genes, rRNA, Metagenome, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.